Literature DB >> 9155855

Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

S P Conway1, A Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9155855      PMCID： PMC1765866          DOI： 10.1136/thx.52.2008.s64

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  41 in total

1.  Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.

Authors:  R E Wood; A Wanner; J Hirsch; P M Farrell
Journal:  Am Rev Respir Dis       Date:  1975-06

2.  Risks of alternate-day prednisone in patients with cystic fibrosis.

Authors:  B J Rosenstein; H Eigen
Journal:  Pediatrics       Date:  1991-02       Impact factor: 7.124

3.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

Review 4.  Therapeutic management of cystic fibrosis.

Authors:  R J Kuhn; M C Nahata
Journal:  Clin Pharm       Date:  1985 Sep-Oct

Review 5.  Consensus conference: practical applications of Pulmozyme. September 22, 1993.

Authors:  B W Ramsey; H L Dorkin
Journal:  Pediatr Pulmonol       Date:  1994-06

6.  Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.

Authors:  D C Weir; A S Robertson; R I Gove; P S Burge
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

7.  Increased physiological dead space during exercise after bronchodilation in cystic fibrosis.

Authors:  G Kusenbach; F Friedrichs; H Skopnik; G Heimann
Journal:  Pediatr Pulmonol       Date:  1993-05

8.  The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.

Authors:  G G Shapiro; J Bamman; P Kanarek; C W Bierman
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

9.  Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Authors:  B W Ramsey; S J Astley; M L Aitken; W Burke; A A Colin; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; D V Schidlow
Journal:  Am Rev Respir Dis       Date:  1993-07

10.  Bronchial hyperreactivity in cystic fibrosis and asthma.

Authors:  I Mitchell; M Corey; R Woenne; I R Krastins; H Levison
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406
View more
  3 in total

Review 1.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 3.  Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome.

Authors:  Chad R Marion; Manuel Izquierdo; Holly C Hanes; Christopher Barrios
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.